Evidence map›Paper›PMID 19352504›Full record

ArticlePloS one2009

Autocatalytic activation of the furin zymogen requires removal of the emerging enzyme's N-terminus from the active site.

Katarzyna Gawlik, Sergey A Shiryaev, Wenhong Zhu, Khatereh Motamedchaboki, Roxane Desjardins, Robert Day, Albert G Remacle, Boguslaw Stec, Alex Y Strongin

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. The Toxoplasma Vacuolar HCell reports · 2019
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Histone H4 promotes prothrombin autoactivation.The Journal of biological chemistry · 2013
    Article
  13. Autoactivation of thrombin precursors.The Journal of biological chemistry · 2013
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. An atypical proprotein convertase in Giardia lamblia differentiation.Molecular and biochemical parasitology · 2011
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Katarzyna GawlikBurnham Institute for Medical Research, La Jolla, California, United States of America.
Sergey A Shiryaev
Wenhong Zhu
Khatereh Motamedchaboki
Roxane Desjardins
Robert Day
Albert G Remacle
Boguslaw Stec
Alex Y Strongin
Sanford Burnham Prebys Medical Discovery Institute · USInstitute for Medical Research · USUniversité de Sherbrooke · CA

Funding

CORE 6 : PROJECT LEADERSHIP AND ADMINISTRATIONU54RR020843 · NCRR · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI SMITH, JEFFREY W · 2004 to 2009
$19.1M
METALLOPROTEINASES IN TUMOR NEOVASCULARIZATIONR01CA083017 · NCI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI STRONGIN, ALEX Y · 1999 to 2014
$3.8M
MT1-MMP pericellular proteolysis in malignancyR01CA077470 · NCI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI STRONGIN, ALEX Y · 1999 to 2009
$3.1M
NCI NIH HHS CA77470NCI NIH HHS CA83017NCI NIH HHS R01 CA077470NCI NIH HHS R01 CA083017NCRR NIH HHS RR020843NCRR NIH HHS U54 RR020843
6 · The paper itself

Abstract

backgroundBefore furin can act on protein substrates, it must go through an ordered process of activation. Similar to many other proteinases, furin is synthesized as a zymogen (profurin) which becomes active only after the autocatalytic removal of its auto-inhibitory prodomain. We hypothesized that to activate profurin its prodomain had to be removed and, in addition, the emerging enzyme's N-terminus had to be ejected from the catalytic cleft. METHODOLOGY/PRINCIPAL

findingsWe constructed and analyzed the profurin mutants in which the egress of the emerging enzyme's N-terminus from the catalytic cleft was restricted. Mutants were autocatalytically processed at only the primary cleavage site Arg-Thr-Lys-Arg(107) downward arrowAsp(108), but not at both the primary and the secondary (Arg-Gly-Val-Thr-Lys-Arg(75) downward arrowSer(76)) cleavage sites, yielding, as a result, the full-length prodomain and mature furins commencing from the N-terminal Asp108. These correctly processed furin mutants, however, remained self-inhibited by the constrained N-terminal sequence which continuously occupied the S' sub-sites of the catalytic cleft and interfered with the functional activity. Further, using the in vitro cleavage of the purified prodomain and the analyses of colon carcinoma LoVo cells with the reconstituted expression of the wild-type and mutant furins, we demonstrated that a three-step autocatalytic processing including the cleavage of the prodomain at the previously unidentified Arg-Leu-Gln-Arg(89) downward arrowGlu(90) site, is required for the efficient activation of furin. CONCLUSIONS/SIGNIFICANCE: Collectively, our results show the restrictive role of the enzyme's N-terminal region in the autocatalytic activation mechanisms. In a conceptual form, our data apply not only to profurin alone but also to a range of self-activated proteinases.

Indexed as

Amino Acid SequenceBase SequenceCatalysisCatalytic DomainCell Line, TumorDNA PrimersEnzyme ActivationEnzyme PrecursorsFurinHumansHydrolysisModels, MolecularMolecular Sequence DataDNA PrimersEnzyme PrecursorsFurin

Identifiers

PMID19352504
PMCPMC2662429
OpenAlexW2001364008

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.